News Jiangsu Aidea Pharmaceutical Co., Ltd.

Equities

688488

CNE1000041S6

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
17.03 ^CNY	+4.74%		+15.22%	+36.13%

Apr. 25	Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Feb. 23	Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 23	CI
Aidea Pharmaceutical, Subsidiaries Get Nod to Trial Anti-HIV Drug	Jan. 09	MT
Aidea Pharmaceutical Unit Scraps Transfer Deal with Lixin Biotechnology for Anti-Tumor Drug	Dec. 27	MT
Aidea Pharmaceutical's HIV Drug Granted Priority Review in China	Nov. 21	MT
China's Drug Regulator Selects Aidea Pharmaceutical's HIV Drug for Priority Review	Nov. 13	MT
Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Jiangsu Aidea Applies For 50 Million Yuan Bank Credit	23-09-01	MT
Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-21	CI
Aidea Pharma to Apply For 50 Million Yuan Bank Loan	23-06-19	MT
Jiangsu Aidea Pharma to Apply For 60 Million Yuan Bank Loan	23-05-25	MT
Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-24	CI
Jiangsu Aidea Pharma to Provide Services to China Medicines and Health Products in Three-Year Agreement	23-03-23	MT
Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
Jiangsu Aidea Pharma Sees Larger Loss in 2022	23-01-25	MT
Jiangsu Aidea Pharma Registers HIV Tablets	23-01-06	MT
Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-28	CI
Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25	CI
Jiangsu Aidea Pharmaceutical Co., Ltd. agreed to acquire 19.9646% stake in Nanjing Nanda Pharmaceutical Co., Ltd. from Jiangsu Sheng Feng Medical Technology Company Limited for CNY 86 million.	22-07-18	CI
Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Jiangsu Aidea Pharmaceutical Co., Ltd.

Equities

688488

CNE1000041S6

Summary

Filters